Topic: Parkinson.
Destination:
Call for grants for pre-clinical research projects to encourage and accelerate the development of anti-Parkinson’s therapies with the potential to fundamentally alter the course of the disease or significantly improve symptom management . To meet this goal, we currently only accept applications from industry groups and academia-industry associations. Specifically, this annuity establishes the following funding priority:
Identify, validate or develop novel pharmacological and non-pharmacological therapies through any of the pre-clinical stages of the therapeutics discovery and development process.
Test repurposed/repositioned therapies hitting priority PD pathways/targets in preclinical PD models
Budget: $250,000-$2,000,000.
Duration: 2 years.
Omple el següent formulari per rebre més informació:
| Galeta | Durada | Descripció |
|---|---|---|
| cookielawinfo-checkbox-analytics | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". |
| cookielawinfo-checkbox-functional | 11 months | The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". |
| cookielawinfo-checkbox-necessary | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". |
| cookielawinfo-checkbox-others | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. |
| cookielawinfo-checkbox-performance | 11 months | This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". |
| viewed_cookie_policy | 11 months | The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. |